Greetings from MyCancerHaven!
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Dr Mateos discusses ongoing cilta-cel research in newly diagnosed myeloma.
Dr Dholaria explores why P-BCMA-ALLO1 is studied in myeloma.
Dr Zonder discusses multiple myeloma epidemiology and its clinical implications.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Dr Mateos discusses ongoing cilta-cel research in newly diagnosed myeloma.
Dr Dholaria explores why P-BCMA-ALLO1 is studied in myeloma.
Dr Zonder discusses multiple myeloma epidemiology and its clinical implications.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
